$ Value
$87K
Shares
2,173
Price
$40
Filed
Jun 18
Insider
Name
Wei Lin
Title
Chief Medical Officer
CIK
0001872772
Roles
Transaction Details
Transaction Date
2025-06-16
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
90,499
Footnotes
Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on December 23, 2024 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after March 15, 2025. | This transaction was executed in multiple trades in prices ranging from $39.6017 to $39.8291, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. | Includes 1,021 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2025. | Includes 64,800 RSUs.
Filing Info
Wei Lin's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-09-16 | RVMD | ▼ | $99K |
| 2025-06-16 | RVMD | ▼ | $87K |
| 2025-05-13 | TSVT | D | — |
| 2025-05-13 | TSVT | U | — |
| 2025-05-13 | TSVT | D | — |
Other Insiders at RVMD (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
GOLDSMITH MARK A
See Remarks
|
— | $18.0M | 2026-04-15 |
|
Mancini Anthony
See Remarks
|
— | $3.6M | 2026-03-25 |